A researcher in a lab looking at a tablet.

Category: ALK Positive News

  • ALK Positive Inc.'s Scientific Advisory Board.
    ,

    ALK Positive Announces Formation of Distinguished Scientific Advisory Board

    ALK Positive, in collaboration with 23andMe Holding Co., a leading genetic health and biopharmaceutical company, and 20 lung cancer advocacy organizations, today announces a new study to help advance research in lung cancer. The focus of the Lung Cancer Genetics Study is to better understand the genetics of people with lung cancer in order to…

    Read More

  • Patty Saccenti (Italy) and Irfan Gilani (Denmark) at the European Lung Cancer Conference.

    MEET YOUR STAFF: Introducing Sadia Yaakov, Medical Project Manager at ALK Positive, Inc

    I was born and raised in Pennsylvania and had an interest in cancer research from the time that I was a child. I was exposed to Fox Chase Cancer Center very early on and knew from that moment that I wanted to do something to help in the fight against cancer. I attended University of…

    Read More

  • Palliative Care with various related illustrations.
    ,

    Palliative Care for ALK-Positive Lung Cancer: Research Identifies a Vital Resource for Improving Quality of Life

    For individuals diagnosed with ALK-positive lung cancer, the mention of palliative care can often lead to confusion or misunderstanding. Many wonder: Why is palliative care recommended? How does it fit into my treatment plan? Do I need it now, or is it something to consider later? Let’s look at the research and explore how palliative…

    Read More

  • Katie Delaney.

    MEET YOUR STAFF: Introducing Katie Delaney, Philanthropy Operations Manager at ALK Positive, Inc.

    With over a decade of entrepreneurship and management experience, I’ve learned one enduring truth: obstacles become opportunities when met with hard work and dedication. Believing that anything is possible with perseverance and self-belief, I’ve discovered that the greatest gift is empowering others to believe in themselves as well.

    Read More

  • Suzanne Houssainy at the ALK Positive summit.

    Introducing ALK Positive, Inc. Executive Director, Suzanne Houssainy

    Suzanne Houssainy was unanimously chosen by the Board of ALK Positive, Inc. for the role among over 300 candidates, many of whom were truly exceptional. We feel that the long, solid experience and professionalism Suzanne brings to the table is going to help our organization get to the next level. Suzanne has over 25 years…

    Read More

  • Terry McGowan, Ken Culver and Dr. Jesse Boehm.
    ,

    Break Through Cancer and ALK Positive, Inc. Team Up to Conquer ALK-Positive Lung Cancer with a $2 Million, Multi-year, Research Partnership

    Break Through Cancer announces a new partnership with ALK Positive Inc. (ALK Positive), a foundation funded by patients with ALK-positive lung cancer and their families. ALK Positive and Break Through Cancer are joining forces to fund a new initiative in lung cancer research with the hope of creating durable responses and cures for patients with…

    Read More

  • ALK Positive Europe – Strengthening the voice of ALK-positive cancer patients in Europe

    ALK Positive Europe (APEU) was founded in 2022 and has its origin in a Facebook group of European patient advocates who were supported in the beginnings by Gina Hollenbeck. In […]

    Read More

  • ALK Positive and Lung Cancer Research Foundation: Expanding Our Research Partnership

    June 15, 2023 – ALK Positive and the Lung Cancer Research Foundation (LCRF) are pleased to announce a groundbreaking research partnership to fund $2 million in ALK-positive lung cancer research over […]

    Read More

  • ,

    Instructions and Call for Patient Participation in The University of Michigan Judith Tam ALK Lung Cancer Research Initiative

    The University of Michigan Judith Tam ALK Lung Cancer Research Initiative is recruiting ALK positive NSCLC patients for extensive and sustained studies of the course of each individual’s disease. Their […]

    Read More

  • ,

    Call for Patient Participation in The University of Michigan Judith Tam ALK Lung Cancer Research Initiative

    The University of Michigan Judith Tam ALK Lung Cancer Research Initiative is recruiting ALK positive NSCLC patients for extensive and sustained studies of the course of each individual’s disease.  Their […]

    Read More

  • Announcing the ALK International Development Alliance (IDA)

    As part of the ALK Positive mission statement the ALK Positive Inc Board of Directors is committed to assisting ALK patients worldwide. Whilst there are many international members in the […]

    Read More

  • ,

    ALK Positive and LUNGevity Foundation Announce Recipients of the 2022 ALK-Positive Research Awards

    To transform advanced ALK-positive lung cancer into a chronic or curable disease, ALK Positive to award $1.75 million through their research award program WASHINGTON, DC (December 1, 2022)— Patient organization […]

    Read More